GPR68 is not only a promising tumor biomarker but also a potential therapeutic target for chronic inflammatory and neoplastic diseases, and it can be used to evaluate the prognosis of patients and select appropriate therapeutic strategies. Here, GPR68 is linked to neoplasm.